Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -66.1%
- Operating Margin Trend -342.18 pp/yr
CYTK
Cytokinetics, Incorporated
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 20.1 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Share-Count CAGR 13.2%
Growth Quality
Weight: 15%
B+
79
- 5yr Revenue CAGR 9.5%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -1778.6%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
F
0
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -7.56x
- Altman Z-Score -2.10
Stability
Weight: 15%
C
54
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 1 new buy; 1 added; 1 trimmed.
- Holders
- 3 +1
- Avg Δ position
- +1191.9%
- New buys
- 1
- Full exits
- 0
- Greenblatt new
- Cooperman increased +2475%
- Wood decreased -91%